Thomas R. Fuerst

University of Maryland, Baltimore — United States

Medicine · Health Sciences

36h-index9.2kcitations101works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(33), Hepatitis C virus research(29), Hepatitis B Virus Studies(20), Virus-based gene therapy research(16), HIV Research and Treatment(13)

Publications101 total

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design
Nature Communications·2026Open Access
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope
2026Open Access
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk
Nature Communications·2025· 3 citedOpen Access
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages
2025· 1 citedOpen Access
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cure
2025· 1 citedOpen Access
Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1
Vaccine·2025Open Access
Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens
Vaccines·2025Open Access
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein‐Protein Interaction Identification in Glycoengineered CHO Cells
Biotechnology Journal·2025· 2 citedOpen Access
Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens
Preprints.org·2025Open Access
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity
npj Vaccines·2025· 5 citedOpen Access
Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers
Communications Biology·2025· 2 citedOpen Access
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO cells
2025Open Access
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design
2025· 2 citedOpen Access
Expression and Characterization of SARS-CoV-2 Spike Protein in <i>Thermothelomyces heterothallica</i> C1
2025Open Access
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicity
2025Open Access
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist—Synthesis, Characterization, and In Vivo Activity
Journal of Functional Biomaterials·2025· 3 citedOpen Access
Expression and Characterization of Sars-Cov-2 Spike Protein in Thermothelomyces Heterothallica C1
SSRN Electronic Journal·2025Open Access
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist – Synthesis, Characterization and In Vivo Activity
Preprints.org·2024· 1 citedOpen Access
A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniation
The Spine Journal·2024· 10 citedOpen Access
97. Efficacy and safety of SI-6603 (condoliase) in radicular leg pain associated with lumbar disc herniation: results from two phase 3, randomized, double-blind controlled trials
The Spine Journal·2024
page 1 of 6Next →

Frequent Co-authors

Bernard Moss(18), Brian G. Pierce(9), Roy A. Mariuzza(8), Steven K. H. Foung(8), Zhen–Yong Keck(7), Alexander K. Andrianov(6), Ruixue Wang(5), Johnathan D. Guest(5), Alexander Marin(5), C. Kendall Stover(4), Patrick Lau(4), Patrice O. Yarbough(4), Eric A. Toth(4), Vidal F. de la Cruz(3), Patricia L. Earl(3), Robert E. Lanford(3), William G. Stetler‐Stevenson(3), Rafael Fridman(3), Robert E. Bird(3), Edward A. Berger(3)